Status:
COMPLETED
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
Determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes mellitus on diet and exercise therapy
Exclusion
- Patients with type 1 diabetes mellitus
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT00363844
Start Date
August 1 2006
Last Update
June 14 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku Region
Chugoku, Japan
2
Chubu Region
Chūbu, Japan
3
Hokkaido Region
Hokkaido, Japan
4
Kanto Region
Kanto, Japan